Effect of NAD(P)H:quinone oxidoreductase on tyrosinase-mediated oxidation of opioid neuropeptides Leu-enkephalin and Met-enkephalin

Biochem Mol Biol Int. 1995 Oct;37(2):319-27.

Abstract

In vitro experiments are reported showing that NAD(P)H:(quinone acceptor) oxidoreductase (QR), purified from Glycine max seedlings, reduces Leu- and Met-enkephalin-tyrosinase oxidation products, in the presence of NADH or NADPH. QR was not capable to catalyze the reduction of N-acetyl-dopaquinone formed by the cation of mushroom tyrosinase on N-acetyl-L-tyrosine, while it was able to reduce dopachrome. The results support the hypothesis that QR can inhibit the formation of melanin-like compounds, as catalyzed by the action of tyrosinase on Leu-enkephalin and Met-enkephalin. It is proposed that, in the presence of NAD(P)H as the electron donor, the inhibition occurs by the specific conversion of the dopachrome-derivative into the reduced precursor, leucodopachrome-derivative.

MeSH terms

  • Enkephalin, Leucine / metabolism*
  • Enkephalin, Methionine / metabolism*
  • Glycine max / enzymology*
  • Monophenol Monooxygenase / metabolism*
  • Monophenol Monooxygenase / pharmacology
  • NAD / metabolism
  • NADP / metabolism
  • Oxidation-Reduction / drug effects
  • Quinone Reductases / metabolism*

Substances

  • NAD
  • NADP
  • Enkephalin, Methionine
  • Enkephalin, Leucine
  • Monophenol Monooxygenase
  • NADPH - phenanthrenequinone oxidoreductase
  • Quinone Reductases